Romosozumab is marketed under which brand name?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $9.99Unlock all

Prepare for the CMS II Rheumatology E1 Exam. Enhance your skills with engaging flashcards, detailed explanations, and multiple-choice questions. Get exam-ready today!

Multiple Choice

Romosozumab is marketed under which brand name?

Explanation:
Romosozumab is a sclerostin inhibitor used to treat osteoporosis, particularly in postmenopausal women at high fracture risk. Its brand name is Evenity, marketed by Amgen. This sets it apart from other osteoporosis therapies: Prolia is denosumab (a RANKL inhibitor), while Fosamax and Actonel are bisphosphonates (alendronate and risedronate, respectively). Recognizing the brand helps you quickly connect the drug to its mechanism and place in therapy.

Romosozumab is a sclerostin inhibitor used to treat osteoporosis, particularly in postmenopausal women at high fracture risk. Its brand name is Evenity, marketed by Amgen. This sets it apart from other osteoporosis therapies: Prolia is denosumab (a RANKL inhibitor), while Fosamax and Actonel are bisphosphonates (alendronate and risedronate, respectively). Recognizing the brand helps you quickly connect the drug to its mechanism and place in therapy.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy